Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

2-MeS-β,γ-CCl2-ATP is a Potent Agent for Reducing Intraocular Pressure

dc.contributor.authorEliahu, Shay
dc.contributor.authorMartín Gil, Alba
dc.contributor.authorPerez de Lara, María Jesús
dc.contributor.authorPintor Just, Jesús Jerónimo
dc.contributor.authorCamden, Jean
dc.contributor.authorWeisman, Gary
dc.contributor.authorLecka, Joanna
dc.contributor.authorSévigny, Jean
dc.contributor.authorFischer, Bilha
dc.date.accessioned2024-02-12T13:21:53Z
dc.date.available2024-02-12T13:21:53Z
dc.date.issued2010
dc.description.abstractExtracellular nucleotides can modify the production or drainage of the aqueous humor via activation of P2 receptors and therefore affect the intraocular pressure (IOP). We have synthesized slowly hydrolyzable nucleoside di- and triphosphate analogues, 1, and 8-14. Analogues 8-14 were completely resistant to hydrolysis by alkaline phosphatase over 30 min at 37 °C. In human blood serum, analogues 8-14 exhibited high stability, e.g., analogues 9 and 10-14 were only 15% and 0% degraded after 24 h, respectively. Moreover, analogues 8-14 were highly stable at pH 1.4 (t1/2 1 h-30 days). Analogues 8-14 were agonists of the P2Y1 receptor (EC50 0.57-9.54 μM). Ocular administration of most analogues into rabbits reduced IOP, e.g., analogue 9 reduced IOP by 32% (EC50 95.5 nM). Analogue 9 was more effective at reducing IOP than several common glaucoma drugs and represents a promising alternative to timolol maleate, which cannot be used for the treatment of patients suffering from asthma or cardiac problems. © 2010 American Chemical Society.
dc.description.departmentDepto. de Optometría y Visión
dc.description.facultyFac. de Óptica y Optometría
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.citationEliahu, Shay, et al. «2-MeS-β,γ-CCl2 -ATP Is a Potent Agent for Reducing Intraocular Pressure». Journal of Medicinal Chemistry, vol. 53, n.o 8, abril de 2010, pp. 3305-19. https://doi.org/10.1021/jm100030u.
dc.identifier.doi10.1021/jm100030u
dc.identifier.essn1520-4804
dc.identifier.issn0022-2623
dc.identifier.officialurlhttps://doi.org/10.1021/jm100030u
dc.identifier.urihttps://hdl.handle.net/20.500.14352/101266
dc.issue.number8
dc.journal.titleJournal of Medicinal Chemistry
dc.language.isoeng
dc.page.final3319
dc.page.initial3305
dc.publisherASC Publications
dc.rights.accessRightsopen access
dc.subject.cdu612.842.6
dc.subject.keywordPresión intraocular
dc.subject.keyword2-MeS-β,γ-CCl2-ATP
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco23 Química
dc.title2-MeS-β,γ-CCl2-ATP is a Potent Agent for Reducing Intraocular Pressure
dc.typejournal article
dc.type.hasVersionAM
dc.volume.number53
dspace.entity.typePublication
relation.isAuthorOfPublication31c5901e-086a-4a75-8243-4baa56947752
relation.isAuthorOfPublicatione8366c14-6aee-427c-8601-f6bf1e360010
relation.isAuthorOfPublication.latestForDiscovery31c5901e-086a-4a75-8243-4baa56947752

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2-MeS-β,γ-CCl2-ATP.pdf
Size:
1.96 MB
Format:
Adobe Portable Document Format

Collections